Valuation: Becton, Dickinson and Company

Market Cap 49.96B 43.15B 40.54B 36.87B 69.32B 4,777B 70.47B 475B 186B 2,392B 188B 183B 7,949B P/E 2026 *
35.3x
P/E 2027 * 19.7x
Enterprise Value 65.84B 56.87B 53.44B 48.6B 91.37B 6,296B 92.87B 626B 245B 3,153B 247B 242B 10,477B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.24x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.18%
1 day+0.79%
1 week+3.70%
Current month+10.74%
1 month+18.41%
3 months+27.83%
6 months+4.27%
Current year-5.50%
1 week 175.63
Extreme 175.63
185.32
1 month 151.97
Extreme 151.97
185.32
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
283.5
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
8/11/26 Sell

EVP and President, EMEA

-2,438 0.0009%
8/6/26 Free

Director

189 0.0001%
8/6/26 Free

Director

94 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%+3.70%-6.40%-34.42% 49.96B
-0.02%+3.19%-15.56%+6.01% 193B
+0.76%+4.72%-1.88%+10.18% 117B
+1.43%-2.07%+7.17%+69.23% 59.89B
+0.32%+3.92%+37.52%+63.82% 56.01B
-1.89%+5.90%+10.87%-21.62% 33.87B
+0.45%+1.45% - - 31.36B
+1.98%+12.62%-2.82%+23.87% 24.77B
+0.94%-1.31%+41.93%-13.11% 24.59B
-1.18%-1.76%-5.00%+1.65% 22.74B
Average +0.36%+3.50%+7.31%+11.73% 61.25B
Weighted average by Cap. +0.36%+3.35%+0.36%+13.63%

Financials

2026 *2027 *
Net sales 19.29B 16.66B 15.66B 14.24B 26.77B 1,845B 27.21B 183B 71.73B 924B 72.43B 70.86B 3,070B 19.73B 17.04B 16.02B 14.57B 27.38B 1,887B 27.84B 188B 73.37B 945B 74.09B 72.48B 3,140B
Net income 1.44B 1.24B 1.17B 1.06B 1.99B 137B 2.03B 13.66B 5.34B 68.79B 5.39B 5.28B 229B 2.34B 2.02B 1.9B 1.73B 3.25B 224B 3.3B 22.25B 8.7B 112B 8.78B 8.59B 372B
Net Debt 15.88B 13.72B 12.89B 11.72B 22.04B 1,519B 22.41B 151B 59.06B 761B 59.64B 58.35B 2,528B 13.95B 12.05B 11.32B 10.3B 19.36B 1,334B 19.68B 133B 51.87B 668B 52.38B 51.24B 2,220B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-08-14 $183.40 +0.79% 1,009,000
26-08-13 $181.97 -0.88% 2,155,407
26-08-12 $183.58 +1.20% 1,551,548
26-08-11 $181.41 +0.99% 1,515,559
26-08-10 $179.63 +1.57% 1,765,859
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
183.40USD
Average target price
194.42USD
Spread / Average Target
+6.01%

Quarterly revenue - Rate of surprise